Acumen Pharmaceuticals Inc (ABOS) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Acumen Pharmaceuticals Inc   (NASDAQ: ABOS)

Acumen Pharmaceuticals Inc Profitability Comparisons

Select each Category to receive further Information




ABOS Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) - 71.11 % 65.43 % 46.08 %
Gross Margin (Q2 TTM) - 79.56 % 66.39 % 46.31 %
Gross Profit Margin 5 Yr. Avg. - 70.97 % 65.56 % 47.82 %
EBITDA Margin (Q2 MRQ) - 20.59 % 19.59 % 20.71 %
EBITDA Margin (Q2 TTM) - 27.11 % 20.86 % 19.16 %
EBITDA Margin 5 Yr. Avg. - 22.75 % 31.58 % 22.44 %
Operating Margin (Q2 MRQ) - 11.28 % 16.57 % 16.03 %
Operating Margin (Q2 TTM) - 16.53 % 17.92 % 16.33 %
Operating Margin 5 Yr. Avg. - 6.03 % 14.33 % 17.24 %
Pre-Tax Profit Margin (Q2 MRQ) - 7.4 % 10.93 % 13.94 %
Pre-Tax Profit Margin (Q2 TTM) - 15.08 % 12.86 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 9.88 % 10.37 % 12.42 %
Net Margin (Q2 MRQ) - 2.64 % 8.14 % 11.4 %
Net Margin (Q2 TTM) - 11.11 % 9.99 % 10.75 %
Net Margin 5 Yr. Avg. - 6.58 % 6.08 % 9.9 %